Guangzhou Wondfo Biotech Co Ltd
Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rhe… Read more
Guangzhou Wondfo Biotech Co Ltd (300482) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.021x
Based on the latest financial reports, Guangzhou Wondfo Biotech Co Ltd (300482) has a cash flow conversion efficiency ratio of 0.021x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥116.99 Million) by net assets (CN¥5.56 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangzhou Wondfo Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Guangzhou Wondfo Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guangzhou Wondfo Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangzhou Wondfo Biotech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Investors Real Estate Trust
F:WXC1
|
0.040x |
|
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658
|
0.051x |
|
NB Bancorp, Inc. Common Stock
NASDAQ:NBBK
|
0.028x |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
0.041x |
|
DINE S.A.B. de C.V
MX:DINEB
|
-0.024x |
|
Transcat Inc
NASDAQ:TRNS
|
0.041x |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
0.006x |
|
VALNEVA SE SP.ADS/2
F:AYJ0
|
N/A |
Annual Cash Flow Conversion Efficiency for Guangzhou Wondfo Biotech Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.65 Billion | CN¥361.71 Million | 0.064x | -23.90% |
| 2023-12-31 | CN¥4.61 Billion | CN¥388.19 Million | 0.084x | -77.31% |
| 2022-12-31 | CN¥4.54 Billion | CN¥1.68 Billion | 0.371x | +95.36% |
| 2021-12-31 | CN¥3.50 Billion | CN¥664.93 Million | 0.190x | -46.50% |
| 2020-12-31 | CN¥2.99 Billion | CN¥1.06 Billion | 0.355x | +181.66% |
| 2019-12-31 | CN¥2.46 Billion | CN¥309.86 Million | 0.126x | +9.42% |
| 2018-12-31 | CN¥2.15 Billion | CN¥247.61 Million | 0.115x | -18.89% |
| 2017-12-31 | CN¥1.19 Billion | CN¥168.85 Million | 0.142x | +8.28% |
| 2016-12-31 | CN¥854.75 Million | CN¥112.01 Million | 0.131x | -30.35% |
| 2015-12-31 | CN¥700.64 Million | CN¥131.81 Million | 0.188x | -43.56% |
| 2014-12-31 | CN¥313.43 Million | CN¥104.47 Million | 0.333x | -20.24% |
| 2013-12-31 | CN¥241.47 Million | CN¥100.91 Million | 0.418x | +1.91% |
| 2012-12-31 | CN¥182.48 Million | CN¥74.84 Million | 0.410x | +148.81% |
| 2011-12-31 | CN¥144.61 Million | CN¥23.83 Million | 0.165x | -- |